Tenon Medical, Inc. TNON
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -46.26% | 3.87% | 8.26% | -4.87% | 27.63% |
| Total Depreciation and Amortization | 12.28% | 42.99% | -12.15% | -11.59% | -24.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -34.29% | -55.62% | -59.00% | -93.63% | -61.03% |
| Change in Net Operating Assets | 58.33% | -229.87% | 111.21% | -195.28% | -87.10% |
| Cash from Operations | -24.57% | -19.21% | 19.91% | -63.21% | 8.51% |
| Capital Expenditure | 10.42% | -- | -618.92% | -514.42% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 10.42% | -- | -618.92% | -514.42% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | 95.60% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 46.41% | -39.03% | 105.67% | -- |
| Cash from Financing | 100.00% | -38.22% | 2,315.93% | -99.39% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.86% | -77.46% | 111.95% | -161.22% | -1.86% |